TA
TXMD icon

Teachers Advisors’s TherapeuticsMD TXMD Stock Holding History

Teachers Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.41M Buy
9,883
+2,434
+33% +$644K ﹤0.01% 1872
2018
Q4 		$1.42M Buy
7,449
+371
+5% +$90.5K ﹤0.01% 2021
2018
Q3 		$2.32M Buy
7,078
+832
+13% +$255K ﹤0.01% 1893
2018
Q2 		$1.95M Buy
6,246
+201
+3% +$61.4K ﹤0.01% 1963
2018
Q1 		$1.47M Hold
6,045
– – ﹤0.01% 2028
2017
Q4 		$1.83M Sell
6,045
-7,296
-55% -$2.03M ﹤0.01% 1902
2017
Q3 		$3.53M Sell
13,341
-88
-0.7% -$25.4K ﹤0.01% 1523
2017
Q2 		$3.54M Buy
13,429
+637
+5% +$160K 0.01% 1498
2017
Q1 		$4.61M Buy
12,792
+181
+1% +$56K 0.01% 1337
2016
Q4 		$3.64M Buy
12,611
+7,853
+165% +$2.43M 0.01% 1442
2016
Q3 		$1.62M Hold
4,758
– – ﹤0.01% 1801
2016
Q2 		$2.02M Buy
4,758
+252
+6% +$104K ﹤0.01% 1649
2016
Q1 		$1.44M Buy
4,506
+738
+20% +$252K ﹤0.01% 1781
2015
Q4 		$1.95M Hold
3,768
– – ﹤0.01% 1617
2015
Q3 		$1.1M Buy
3,768
+63
+2% +$22.4K ﹤0.01% 1940
2015
Q2 		$1.46M Buy
3,705
+427
+13% +$151K ﹤0.01% 1899
2015
Q1 		$992K Buy
3,278
+409
+14% +$99.8K ﹤0.01% 2035
2014
Q4 		$638K Hold
2,869
– – ﹤0.01% 2305
2014
Q3 		$666K Hold
2,869
– – ﹤0.01% 2238
2014
Q2 		$634K Buy
2,869
+123
+4% +$27.4K ﹤0.01% 2302
2014
Q1 		$866K Buy
2,746
+367
+15% +$117K ﹤0.01% 2107
2013
Q4 		$620K Buy
2,379
+47
+2% +$10.3K ﹤0.01% 2267
2013
Q3 		$342K Buy
2,332
+262
+13% +$31.7K ﹤0.01% 2549
2013
Q2 		$314K Buy
+2,070
New +$284K ﹤0.01% 2516

Other funds holding TXMD

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Teachers Advisors's TXMD Position: Q1 2019 in Review

Teachers Advisors increased its TherapeuticsMD (TXMD) stake by 33% in Q1 2019, buying an estimated $644K and bringing the position to 9,883 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1872.

Teachers Advisors first reported a position in TXMD in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.61M in Q1 2017. 146 funds tracked by Wall St. Rank hold TXMD as of Q1 2019.

  • Teachers Advisors held 9,883 shares of TherapeuticsMD worth $2.41M as of Q1 2019.
  • Teachers Advisors bought 2,434 TherapeuticsMD shares in Q1 2019, an estimated $644K.
  • TherapeuticsMD made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1872 holding.
  • Teachers Advisors first reported a position in TherapeuticsMD in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's TherapeuticsMD position peaked at $4.61M in Q1 2017.
  • 146 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.